DNOW Q1 2026 Earnings Significant EPS Miss Amid Challenging Environment INLX Q1 2026 Earnings Significant EPS Miss Raises Concerns Envoy Medical Q1 2026 Earnings EPS Surprises to the Upside Despite No Revenue Stock Declines TFIN Q1 2026 Earnings EPS Surpasses Estimates by 569 on Strong Core Operations FibroBiologics FBLG Q1 2026 Earnings Narrow EPS Miss as PreRevenue Biotech Continues RD Investment MTDR Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response